Literature DB >> 12853821

AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations.

.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12853821     DOI： 10.1097/01.ju.0000078083.38675.79

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  219 in total

Review 1.  The role of 5-alpha-reductase inhibition as monotherapy in view of the MTOPS data.

Authors:  Jaspreet S Sandhu; Alexis E Te
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 3.092

2.  Clinical pearls in men's health.

Authors:  Thomas J Beckman; Scott C Litin
Journal:  Mayo Clin Proc       Date:  2010-07       Impact factor: 7.616

3.  2010 Update: Guidelines for the management of benign prostatic hyperplasia.

Authors:  J Curtis Nickel; Carlos E Méndez-Probst; Thomas F Whelan; Ryan F Paterson; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

4.  Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial.

Authors:  Michael J Barry; Sreelatha Meleth; Jeannette Y Lee; Karl J Kreder; Andrew L Avins; J Curtis Nickel; Claus G Roehrborn; E David Crawford; Harris E Foster; Steven A Kaplan; Andrew McCullough; Gerald L Andriole; Michael J Naslund; O Dale Williams; John W Kusek; Catherine M Meyers; Joseph M Betz; Alan Cantor; Kevin T McVary
Journal:  JAMA       Date:  2011-09-28       Impact factor: 56.272

5.  Fluid manipulation among individuals with lower urinary tract symptoms: a mixed methods study.

Authors:  Emily A Elstad; Nancy N Maserejian; John B McKinlay; Sharon L Tennstedt
Journal:  J Clin Nurs       Date:  2010-11-15       Impact factor: 3.036

Review 6.  Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?

Authors:  Abdulmaged M Traish; Roberto Cosimo Melcangi; Marco Bortolato; Luis M Garcia-Segura; Michael Zitzmann
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

Review 7.  Transurethral enucleation of the prostate versus transvesical open prostatectomy for large benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Youcheng Lin; Xun Wu; Abai Xu; Rui Ren; Xueqiong Zhou; Yong Wen; Yong Zou; Mancheng Gong; Chunxiao Liu; Zexuan Su; Thomas R W Herrmann
Journal:  World J Urol       Date:  2015-12-23       Impact factor: 4.226

8.  Management of Male Lower Urinary Tract Symptoms in a Simulated, Over-the-Counter Setting: An Exploratory Study of Tamsulosin.

Authors:  Claus G Roehrborn; Franklin C Lowe; Marc Gittelman; Jan M Wruck; Anna E Verbeek
Journal:  Drugs Aging       Date:  2019-02       Impact factor: 3.923

9.  Demographic and comorbidity profile of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a real-life clinical setting: Are 5-alpha-reductase inhibitor consumers different?

Authors:  Ferdinando Fusco; Davide Arcaniolo; Massimiliano Creta; Gaetano Piccinocchi; Giovanni Arpino; Matteo Laringe; Roberto Piccinocchi; Nicola Longo; Paolo Verze; Francesco Mangiapia; Vittorio Imperatore; Vincenzo Mirone
Journal:  World J Urol       Date:  2014-12-10       Impact factor: 4.226

10.  Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.

Authors:  Jeannette Lee; Gerald Andriole; Andrew Avins; E David Crawford; Harris Foster; Steven Kaplan; Karl Kreder; John Kusek; Andrew McCullough; Kevin McVary; Sreelatha Meleth; Michael Naslund; J Curtis Nickel; Leroy Nyberg; Claus Roehrborn; O Dale Williams; Michael Barry
Journal:  Clin Trials       Date:  2009-12-09       Impact factor: 2.486
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.